Randomized controlled trials in pouchitis

Reviews on Recent Clinical Trials

Volumn 7, Issue 4, 2012, Pages 303-306

  Gionchetti, P ^a   Calafiore, A ^a   Pratico C ^a   Laureti, S ^a   Vitali, G ^a   Poggioli, G ^a   Campieri, M ^a   Rizzello, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antibiotics; Ileal pouch anal anastomosis; Pouchitis; Probiotics

Indexed keywords

ALICAFORSEN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; BIOLOGICAL FACTOR; BUDESONIDE; BUTYRIC ACID; CIPROFLOXACIN; GLUTAMINE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; TINIDAZOLE; TUMOR NECROSIS FACTOR INHIBITOR;

ACUTE DISEASE; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC DISEASE; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG RESPONSE; HUMAN; ILEITIS; MAINTENANCE THERAPY; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SCORING SYSTEM; UNSPECIFIED SIDE EFFECT;

EID: 84874919429     PISSN: 15748871     EISSN: 18761038     Source Type: Journal    
DOI: 10.2174/1574887111207040303     Document Type: Article

References (36)

1. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomosis: complications and function in 1005 patients. Ann Surg 1995; 222: 120-7.
2. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107: 1856-60.
3. Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497-500.
4. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998; 85: 800-3.
5. Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouchanal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234-9.
6. Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000; 24: 851-6.
7. Shen B, Fazio VW, Remzi FH, Lashner BA. Clinical approach to diseases of ileal pouch-anal anastomosis. Am J Gastroenterol 2005; 100: 2796-807.
8. Stahlberg D, Gullberg K, Lilijeqvist L, Hellers G, Lofberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996; 39: 1012-18.
9. Svaninger G, Nordgren S, Oresland T, Hulten L. Incidence and characteristics of pouchitis in the Koch continent ileostomy and the pelvic pouch. Scan J Gastroenterol 1993; 28: 695-700.
10. Penna C, Tiret E, Kartheuser A, et al. Function of ileal J pouchanal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 765-7.
11. Tjandra JJ, Fazio VW, Church JM, et al. Similar functional results after restorautive proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993; 165: 322-5.
12. Dozois RR, Goldberg SM, Rothenberger DA, et al. Restorative proctocolectomy with ileal reservoir. Int J Colorectal Dis 1986; 1: 2-19.
13. Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 261-7.
14. Pardi DS, Sandborn WJ. Systematic review: the management of pouchitis. Aliment Pharmacol Ther 2006; 23: 1087-96.
15. Heuschen UA, Allemeyer EH, Hinz U, et al. Diagnosing pouchitis: comparative validation of two scoring systems in routine followup. Dis Colon Rectum 2002; 45: 776-86.
16. Sandborn W, McLeod R, Jewell D. Pharmacotherapy for inducing and maintaining remission in pouchitis. Cochrane Database Syst Rev 2000; 2: CD001176.
17. Hurst RD, Molinari M, Chung P, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497-502.
18. Madden M, McIntyre A, Nicholls RJ. Double-blind cross-over trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994; 39: 1193-96.
19. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001; 7: 301-5.
20. Holubar SD, Cima RR, Sandborn WJ, Pardi DS. Treatment and prevention of pouchitis after ileal-pouch anal anastomosis for ulcerative colitis. Cochrane Database Syst Rev 2010; 6: CD001176.
21. Shen B, Fazio VW, Remzi FH, et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum 2007; 50: 498-508.
22. Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713-8.
23. Abdelrazeq AS, Kelly SM, Lund JN, Leveson SH. Rifaximinciprofloxacin combination therapy is effective in chronic active refractory pouchitis. Colorectal Dis 2005; 7: 182-6.
24. Mimura T, Rizzello F, Helwig U, et al. Four week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-917.
25. Gionchetti P, Rizzello F, Morselli C, et al. Oral budesonide in the treatment of chronic refractory pouchitis. Aliment Pharmacol Ther 2007; 25: 1231-6.
26. Sambuelli A, Boerr L, Negreira S, Gil A, Camartino G, Huernos S et al. Budesonide enema in pouchitis. A double-blind, doubledummy, controlled trial. Aliment Pharmacol Ther 2002; 16: 27-34.
27. Winter TA, Dalton HR, Merrett MN, Campbell A, Jewell DP. Cyclosporine A retention enemas in refractory distal ulcerative colitis and pouchitis. Scand J Gastroenterol 1993; 28: 701-4.
28. De Silva HJ, Ireland A, Kettlewell M, Mortensen N, Jewell DP. Short-chain fatty acid irrigation in severe pouchitis. N Engl J Med 1989; 321: 416-7.
29. Tremaine WJ, Sandborn WJ, Phillips SF, et al. Short-chain fatty acid (SCFA) enema therapy for treatment-resistant pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis. Gastroenterology 1999; 106: A784.
30. Wischmeyer P, Pemberton JH, Phillips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993; 68: 978-81.
31. Ferrante M, D'Haens G, Dewit O, et al. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series. Inflamm Bowel Dis 2010; 16: 243-9.
32. Calabrese C, Gionchetti P, Rizzello F, et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008; 27: 759-64
33. Miner P Jr, Wedel M, Bane B, Bradley J. An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis. Aliment Pharmacol Ther 2004; 19: 281-6.
34. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a doubleblind, placebo-controlled trial. Gastroenterology 2000; 119: 305-9.
35. Mimura T, Rizzello F, Helwig U et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-14.
36. Gionchetti P, Rizzello F, Helvig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind placebo controlled trial. Gastroenterology 2003; 124: 1202-9.